罗兵咸发表上半年新股市场回顾，期内47只新股共集资2,129.6亿元。 罗兵咸永道香港资本市场服务合夥人黄金钱指出，今年上半年同股不同权、生物科技、医药及TMT行业等新经济IPO共录23宗，合计集资1,492亿元，占期内集资额的70%，较去年同期的84%下降。他指出，数据反映前内新股百花齐放，市场不单单只依赖新经济支撑。该行预测香港全年共有150家公司上市，当中145只为主板新股。 罗兵咸永道香港企业客户主管合夥人黄炜邦指出，目前正在排队的上市申请超过200宗，6月份更录得61宗申请，有信心新股市场维持增长及活跃，大市气氛向好，将全年集资额预测由4,600亿元提升至5,000亿元，即按年增长约25%。按集资额计，香港今年於全球排名有机会继续跻身三甲。他预期，下半年将有5至7家集资100亿元以上的超大型新股上市，共集资750亿至1,000亿元，包括电动汽车及环保相关大型ESG企业、消费品及零售服务公司。集资50亿至100亿元预期共有5至10家，共筹集350亿至700亿元；另外集资50亿元以下新股料超过80家，平均集资约15亿元。罗兵咸预期，ESG相关大型企业共有5至6家，将集资共500亿元以上，生物科技公司将有28至30家，筹集700亿至750亿元。(gc/k)~阿思达克财经新闻网址: www.aastocks.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments